FOG-001 in Locally Advanced or Metastatic Solid Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Ogólny stan zdrowia pozwalający na aktywność codzienną (ocena 0-1)
- •Odpowiednia funkcja narządów wewnętrznych i szpiku kostnego
- •Nowotwór, który nie reaguje na wcześniejsze leczenie
- •Określone mutacje genetyczne w genie APC lub CTNNB1
- •Rak jelita grubego bez wysokiej niestabilności mikrosatelitów
- •U pacjentów z rakiem wątroby: potwierdzenie nowotworu oraz określone mutacje
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 23, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (33)
Mayo Clinic
Phoenix, United States
Honor Health
Scottsdale, United States
Arizona Cancer Center at University of Arizona
Tucson, United States
University of California, Los Angeles (UCLA)
Los Angeles, United States
Stanford Cancer Institute, Stanford University
Palo Alto, United States
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center
San Francisco, United States
Sarcoma Oncology Center
Santa Monica, United States
University of Colorado
Aurora, United States
Yale University School of Medicine
New Haven, United States
Johns Hopkins University, Sibley Memorial Hospital
Washington D.C., United States
Mayo Clinic
Jacksonville, United States
Florida Cancer Specialists
Lake Mary, United States
Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center
Baltimore, United States
Massachusetts General Hospital
Boston, United States
Dana Farber Cancer Institute
Boston, United States
M Health Fairview University of Minnesota Medical Center
Minneapolis, United States
Mayo Clinic
Rochester, United States
Washington University School of Medicine
St Louis, United States
Memorial Sloan Kettering Cancer Center
New York, United States
Duke University
Durham, United States
University Hospitals Cleveland Medical Center, Seidman Cancer Center
Cleveland, United States
Cleveland Clinic
Cleveland, United States
Oregon Health and Science University
Portland, United States
University of Pennsylvania, Perelman School of Medicine
Philadelphia, United States
University of Pittsburgh Medical Center, Hillman Cancer Center
Pittsburgh, United States
Sarah Cannon Research Institute
Nashville, United States
Vanderbilt Ingram Cancer Center
Nashville, United States
The University of Texas MD Anderson Cancer Center
Houston, United States
South Texas Accelerated Research Therapeutics, LLC
San Antonio, United States
University of Virginia
Charlottesville, United States
University of Wisconsin, Carbone Cancer Center
Madison, United States
Integrated Clinical Oncology Network (ICON)
South Brisbane, Australia
Peter MacCallum Cancer Centre
Melbourne, Australia
Trial contact
Clinical Trial Inquiries
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/24/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.